logo-loader
viewPolarean Imaging PLC

Polarean Imaging delivers latest research unit

The order for the 9820 Xenon Polariser system was from the University of British Columbia

Polarean Imaging PLC -
The company has developed a drug-device combination which uses xenon gas as a contrast agent in magnetic resonance imaging

Polarean Imaging PLC (LON:POLX) has installed its latest research unit at a hospital in Vancouver, Canada.

The order for the 9820 Xenon Polariser system was from the University of British Columbia, but the unit will be installed at the BC Children's Hospital, a leading paediatric research and teaching centre.

Polarean chief executive Richard Hullihen said: "We have now delivered and installed our latest polariser, which is a platform for the researchers at BC Children's Hospital, expanding our paediatric research cluster which includes Cincinnati Children's Hospital Medical Center and Toronto SickKids Hospital.

“We look forward to enabling their new discoveries in these critical projects and we welcome UBC to the group."

The company has developed a drug-device combination which uses xenon gas as a contrast agent in magnetic resonance imaging.

By inhaling and holding a small amount of the gas for just a few seconds, the patient is able to create a much stronger MRI signal, providing doctors with multiple images of lung structure and function.

Quick facts: Polarean Imaging PLC

Price: 20 GBX

AIM:POLX
Market: AIM
Market Cap: £22.89 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Polarean Imaging PLC named herein, including the promotion by the Company of Polarean Imaging PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Polarean Imaging eagerly awaiting readouts from its key phase III clinical...

Polarean Imaging PLC's (LON:POLX) Richard Hullihen speaks to Proactive London's Andrew Scott following the news they've now completed patient enrolment for the phase III clinical trials of its MRI lung scan technology. He says the trials are now in the image and statistical analysis stage, a...

4 weeks, 1 day ago

2 min read